Communication FSMA_2021_06 (available in French – Dutch only) informs companies of the entry into force of European Regulation (EU) 2019/2088 on sustainability-related disclosures in the financial services sector (also known as the ‘Disclosure Regulation’ or ‘SFDR’). It clarifies the rules that apply both to companies and to products, as well as the expectations of the FSMA in this […]
The FSMA is launching a series of animated films (available in French and Dutch only) about the rules intended to combat money laundering and terrorist financing. The films are intended to help insurance intermediaries to apply the anti-money laundering rules correctly. Via a new series of animated films, the FSMA seeks to raise the awareness […]
ANNOUNCEMENT BY THE FINANCIAL SERVICES AND MARKETS AUTHORITY, PUBLISHED IN APPLICATION OF ARTICLE 78 OF THE LAW OF 21 NOVEMBER 2017 Trading in the financial instruments of Xior, ISIN BE0974288202, on Euronext Brussels will re-open on 05/03/2021 at 14:45 CET. Source: FSMA
ANNOUNCEMENT BY THE FINANCIAL SERVICES AND MARKETS AUTHORITY, PUBLISHED IN APPLICATION OF ARTICLE 78 OF THE LAW OF 21 NOVEMBER 2017 Trading in the financial instruments of Xior, ISIN BE0974288202 , on Euronext Brussels is suspended on the request of the company from 5/3/2021 at 09:00 CET until the publication of a press release. Source: […]
The Financial Services and Markets Authority (FSMA) warns the public against the irregular activities of Antares, which is active via www.antares.trade. This company offers investment services in Belgium without respecting the Belgian financial legislation. Antares is not authorized as an investment firm in Belgium. Antares is therefore not allowed to provide investment services in Belgium. […]
ANNOUNCEMENT BY THE FINANCIAL SERVICES AND MARKETS AUTHORITY, PUBLISHED IN APPLICATION OF ARTICLE 78 OF THE LAW OF 21 NOVEMBER 2017 Trading in the financial instruments of ASIT Biotech, ISIN BE0974289218, on Euronext Brussels will re-open on 18/03/2021 at 09:00 CET. Source: FSMA
Regulated companies that produce or sell financial instruments must meet the MiFID II requirements as regards product governance. These rules differ depending on the role played by the companies in this area. The FSMA wishes to help companies comply with these new product governance requirements by offering them a work programme (available in French or Dutch only). […]
ANNOUNCEMENT BY THE FINANCIAL SERVICES AND MARKETS AUTHORITY, PUBLISHED IN APPLICATION OF ARTICLE 78 OF THE LAW OF 21 NOVEMBER 2017 Trading in the financial instruments of ASIT Biotech, ISIN BE0974289218, on Euronext Brussels is suspended on the request of the company from 17/03/2021 at 09:00 CET until the publication of a press release. […]
The FSMA is launching a series of animated films (available in French and Dutch only) about the rules intended to combat money-laundering and terrorist financing. The films are intended to help insurance intermediaries to apply these rules correctly. Via these new films, the FSMA seeks to raise the awareness of insurance intermediaries active in the […]
Mr Jean-Paul Servais, the Chairman of the FSMA, delivered the closing keynote at the yearly EU-Asia Financial Services Dialogue organised by Asifma and Afore, in which more than 450 persons participated digitally. His remarks focused on the recent developments in the international landscape for sustainable finance and sustainability disclosures by public companies. Mr Servais is […]